State of Illinois
91st General Assembly
Legislation

   [ Search ]   [ Legislation ]
[ Home ]   [ Back ]   [ Bottom ]



91_HB0148

 
                                               LRB9100184RCpc

 1        AN ACT to amend the Illinois Controlled Substances Act by
 2    changing Section 102 and adding Section 316.

 3        Be it enacted by the People of  the  State  of  Illinois,
 4    represented in the General Assembly:

 5        Section  5.   The  Illinois  Controlled Substances Act is
 6    amended by changing Section 102 and  adding  Section  316  as
 7    follows:

 8        (720 ILCS 570/102) (from Ch. 56 1/2, par. 1102)
 9        Sec.  102.  Definitions.  As used in this Act, unless the
10    context otherwise requires:
11        (a)  "Addict" means any person who  habitually  uses  any
12    drug,  chemical,  substance  or  dangerous  drug  other  than
13    alcohol  so  as to endanger the public morals, health, safety
14    or welfare or who  is  so  far  addicted  to  the  use  of  a
15    dangerous  drug or controlled substance other than alcohol as
16    to have lost the power of self control with reference to  his
17    addiction.
18        (b)  "Administer"  means  the  direct  application  of  a
19    controlled   substance,  whether  by  injection,  inhalation,
20    ingestion, or any other means, to the body of  a  patient  or
21    research subject by:
22             (1)  a  practitioner  (or,  in  his presence, by his
23        authorized agent), or
24             (2)  the patient or research subject at  the  lawful
25        direction of the practitioner.
26        (c)  "Agent"  means  an  authorized  person  who  acts on
27    behalf of or at the direction of a manufacturer, distributor,
28    or dispenser.  It does  not  include  a  common  or  contract
29    carrier,  public  warehouseman  or employee of the carrier or
30    warehouseman.
31        (c-1)  "Anabolic Steroids" means  any  drug  or  hormonal
 
                            -2-                LRB9100184RCpc
 1    substance,   chemically   and  pharmacologically  related  to
 2    testosterone   (other   than   estrogens,   progestins,   and
 3    corticosteroids) that promotes muscle growth, and includes:
 4                  (i)  boldenone,
 5                  (ii)  chlorotestosterone,
 6                  (iii)  chostebol,
 7                  (iv)  dehydrochlormethyltestosterone,
 8                  (v)  dihydrotestosterone,
 9                  (vi)  drostanolone,
10                  (vii)  ethylestrenol,
11                  (viii)  fluoxymesterone,
12                  (ix)  formebulone,
13                  (x)  mesterolone,
14                  (xi)  methandienone,
15                  (xii)  methandranone,
16                  (xiii)  methandriol,
17                  (xiv)  methandrostenolone,
18                  (xv)  methenolone,
19                  (xvi)  methyltestosterone,
20                  (xvii)  mibolerone,
21                  (xviii)  nandrolone,
22                  (xix)  norethandrolone,
23                  (xx)  oxandrolone,
24                  (xxi)  oxymesterone,
25                  (xxii)  oxymetholone,
26                  (xxiii)  stanolone,
27                  (xxiv)  stanozolol,
28                  (xxv)  testolactone,
29                  (xxvi)  testosterone,
30                  (xxvii)  trenbolone, and
31                  (xxviii)  any salt, ester, or isomer of a  drug
32             or  substance described or listed in this paragraph,
33             if that  salt,  ester,  or  isomer  promotes  muscle
34             growth.
 
                            -3-                LRB9100184RCpc
 1        Any  person who is otherwise lawfully in possession of an
 2    anabolic steroid, or  who  otherwise  lawfully  manufactures,
 3    distributes, dispenses, delivers, or possesses with intent to
 4    deliver  an  anabolic  steroid,  which  anabolic  steroid  is
 5    expressly   intended   for   and   lawfully   allowed  to  be
 6    administered through implants to livestock or other  nonhuman
 7    species, and which is approved by the Secretary of Health and
 8    Human  Services for such administration, and which the person
 9    intends to  administer  or  have  administered  through  such
10    implants,  shall  not  be  considered  to  be in unauthorized
11    possession  or   to   unlawfully   manufacture,   distribute,
12    dispense,  deliver,  or  possess  with intent to deliver such
13    anabolic steroid for purposes of this Act.
14        (d)  "Administration"   means   the   Drug    Enforcement
15    Administration,  United  States Department of Justice, or its
16    successor agency.
17        (d-5)  "Animal  control  facility"  means  any   facility
18    operated  by  or under contract for the State, county, or any
19    municipal corporation or political subdivision of  the  State
20    for  the  purpose  of  impounding or harboring seized, stray,
21    homeless,  abandoned  or  unwanted  dogs,  cats,  and   other
22    animals.  "Animal control facility" also means any veterinary
23    hospital   or   clinic   operated   by   a   veterinarian  or
24    veterinarians licensed  under  the  Veterinary  Medicine  and
25    Surgery  Practice  Act  of  1994  that operates for the above
26    mentioned purpose in addition to its customary purposes.
27        (d-10)  "Animal  shelter"  means  a  facility   operated,
28    owned,  or  maintained by a duly incorporated humane society,
29    animal welfare society, or other non-profit organization  for
30    the  purpose  of  providing  for  and  promoting the welfare,
31    protection,  and  humane  treatment  of   animals.    "Animal
32    shelter"   also  means  any  veterinary  hospital  or  clinic
33    operated by a veterinarian or  veterinarians  licensed  under
34    the Veterinary Medicine and Surgery Practice Act of 1994 that
 
                            -4-                LRB9100184RCpc
 1    operates  for  the above mentioned purpose in addition to its
 2    customary purposes.
 3        (e)  "Control" means to add a drug or other substance, or
 4    immediate precursor, to a Schedule under Article II  of  this
 5    Act whether by transfer from another Schedule or otherwise.
 6        (f)  "Controlled  Substance"  means a drug, substance, or
 7    immediate precursor in the Schedules of Article  II  of  this
 8    Act.
 9        (g)  "Counterfeit    substance"    means   a   controlled
10    substance, which, or the  container  or  labeling  of  which,
11    without  authorization  bears  the  trademark, trade name, or
12    other identifying mark, imprint, number  or  device,  or  any
13    likeness   thereof,   of   a  manufacturer,  distributor,  or
14    dispenser other than the person  who  in  fact  manufactured,
15    distributed, or dispensed the substance.
16        (h)  "Deliver"    or   "delivery"   means   the   actual,
17    constructive  or  attempted  transfer  of  possession  of   a
18    controlled  substance, with or without consideration, whether
19    or not there is an agency relationship.
20        (i)  "Department" means the Illinois Department of  Human
21    Services  (as  successor  to the Department of Alcoholism and
22    Substance Abuse) or its successor agency.
23        (j)  "Department of State Police" means the Department of
24    State Police of  the  State  of  Illinois  or  its  successor
25    agency.
26        (k)  "Department  of Corrections" means the Department of
27    Corrections of the State of Illinois or its successor agency.
28        (l)  "Department of Professional  Regulation"  means  the
29    Department   of  Professional  Regulation  of  the  State  of
30    Illinois or its successor agency.
31        (m)  "Depressant" or "stimulant substance" means:
32             (1)  a drug  which  contains  any  quantity  of  (i)
33        barbituric  acid  or  any of the salts of barbituric acid
34        which has been designated as habit forming under  section
 
                            -5-                LRB9100184RCpc
 1        502  (d)  of the Federal Food, Drug, and Cosmetic Act (21
 2        U.S.C. 352 (d)); or
 3             (2)  a drug  which  contains  any  quantity  of  (i)
 4        amphetamine  or  methamphetamine and any of their optical
 5        isomers; (ii) any salt of amphetamine or  methamphetamine
 6        or any salt of an optical isomer of amphetamine; or (iii)
 7        any  substance which the Department, after investigation,
 8        has found to be, and by rule designated as, habit forming
 9        because of its depressant  or  stimulant  effect  on  the
10        central nervous system; or
11             (3)  lysergic acid diethylamide; or
12             (4)  any  drug  which  contains  any  quantity  of a
13        substance which the Department, after investigation,  has
14        found  to  have,  and  by  rule  designated  as having, a
15        potential  for  abuse  because  of  its   depressant   or
16        stimulant  effect  on  the  central nervous system or its
17        hallucinogenic effect.
18        (n)  "Designated  product"  means  any   narcotic   drug,
19    amphetamine,  phenmetrazine,  methamphetamine, gluthethimide,
20    pentazocine or cannabis product listed  in  Schedule  II  and
21    also means a controlled substance listed in Schedule II which
22    is  determined  and  designated  by  the  Department  or  its
23    successor  agency  to be such a product. A designated product
24    shall only be dispensed upon an official prescription blank.
25        (o)  "Director" means the Director of the  Department  of
26    State  Police or the Department of Professional Regulation or
27    his designated agents.
28        (p)  "Dispense" means to deliver a  controlled  substance
29    to an ultimate user or research subject by or pursuant to the
30    lawful  order  of  a  prescriber,  including the prescribing,
31    administering, packaging, labeling, or compounding  necessary
32    to prepare the substance for that delivery.
33        (q)  "Dispenser" means a practitioner who dispenses.
34        (r)  "Distribute"   means   to  deliver,  other  than  by
 
                            -6-                LRB9100184RCpc
 1    administering or dispensing, a controlled substance.
 2        (s)  "Distributor" means a person who distributes.
 3        (t)  "Drug" means (1) substances recognized as  drugs  in
 4    the    official   United   States   Pharmacopoeia,   Official
 5    Homeopathic Pharmacopoeia of the United States,  or  official
 6    National  Formulary,  or  any  supplement to any of them; (2)
 7    substances intended for use in diagnosis,  cure,  mitigation,
 8    treatment,  or  prevention  of disease in man or animals; (3)
 9    substances (other than food) intended to affect the structure
10    of any function of  the  body  of  man  or  animals  and  (4)
11    substances  intended  for  use  as a component of any article
12    specified in clause (1), (2), or (3) of this subsection.   It
13    does  not  include  devices  or  their  components, parts, or
14    accessories.
15        (u)  "Good faith" means the prescribing or dispensing  of
16    a  controlled  substance  by  a  practitioner  in the regular
17    course of professional treatment to or for any person who  is
18    under  his  treatment for a pathology or condition other than
19    that individual's physical or psychological  dependence  upon
20    or  addiction  to  a controlled substance, except as provided
21    herein:  and application of the term to  a  pharmacist  shall
22    mean the dispensing of a controlled substance pursuant to the
23    prescriber's  order which in the professional judgment of the
24    pharmacist is lawful.  The  pharmacist  shall  be  guided  by
25    accepted professional standards including, but not limited to
26    the following, in making the judgment:
27             (1)  lack    of    consistency   of   doctor-patient
28        relationship,
29             (2)  frequency of prescriptions for same drug by one
30        prescriber for large numbers of patients,
31             (3)  quantities beyond those normally prescribed,
32             (4)  unusual dosages,
33             (5)  unusual geographic distances  between  patient,
34        pharmacist and prescriber,
 
                            -7-                LRB9100184RCpc
 1             (6)  consistent prescribing of habit-forming drugs.
 2        (u-1)  "Home  infusion  services" means services provided
 3    by  a  pharmacy   in   compounding   solutions   for   direct
 4    administration to a patient in a private residence, long-term
 5    care  facility,  or  hospice  setting by means of parenteral,
 6    intravenous,  intramuscular,  subcutaneous,  or   intraspinal
 7    infusion.
 8        (v)  "Immediate precursor" means a substance:
 9             (1)  which  the  Department  has  found to be and by
10        rule designated as being a principal  compound  used,  or
11        produced  primarily  for  use,  in  the  manufacture of a
12        controlled substance;
13             (2)  which is  an  immediate  chemical  intermediary
14        used  or  likely  to  be  used in the manufacture of such
15        controlled substance; and
16             (3)  the control of which is necessary  to  prevent,
17        curtail  or  limit  the  manufacture  of  such controlled
18        substance.
19        (w)  "Instructional  activities"  means   the   acts   of
20    teaching,  educating  or  instructing  by practitioners using
21    controlled substances within educational facilities  approved
22    by the State Board of Education or its successor agency.
23        (x)  "Local  authorities"  means  a duly organized State,
24    County or Municipal peace unit or police force.
25        (y)  "Look-alike substance" means a substance, other than
26    a controlled substance  which  (1)  by  overall  dosage  unit
27    appearance,  including  shape,  color, size, markings or lack
28    thereof,  taste,  consistency,  or  any   other   identifying
29    physical  characteristic  of  the  substance,  would  lead  a
30    reasonable   person  to  believe  that  the  substance  is  a
31    controlled  substance,  or  (2)  is  expressly  or  impliedly
32    represented to be a controlled substance  or  is  distributed
33    under  circumstances  which would lead a reasonable person to
34    believe that the substance is a controlled substance. For the
 
                            -8-                LRB9100184RCpc
 1    purpose of determining whether the  representations  made  or
 2    the circumstances of the distribution would lead a reasonable
 3    person  to believe the substance to be a controlled substance
 4    under this clause (2) of subsection (y), the court  or  other
 5    authority  may  consider the following factors in addition to
 6    any other factor that may be relevant:
 7             (a)  statements made  by  the  owner  or  person  in
 8        control  of  the  substance concerning its nature, use or
 9        effect;
10             (b)  statements made to the buyer or recipient  that
11        the substance may be resold for profit;
12             (c)  whether  the  substance is packaged in a manner
13        normally used for the illegal distribution of  controlled
14        substances;
15             (d)  whether    the    distribution   or   attempted
16        distribution included an exchange of or demand for  money
17        or  other  property  as  consideration,  and  whether the
18        amount of the  consideration  was  substantially  greater
19        than the reasonable retail market value of the substance.
20        Clause  (1)  of  this subsection (y) shall not apply to a
21    noncontrolled substance in its finished dosage form that  was
22    initially  introduced  into  commerce  prior  to  the initial
23    introduction into commerce of a controlled substance  in  its
24    finished dosage form which it may substantially resemble.
25        Nothing  in  this subsection (y) prohibits the dispensing
26    or  distributing  of  noncontrolled  substances  by   persons
27    authorized  to  dispense and distribute controlled substances
28    under this Act, provided that such action would be deemed  to
29    be  carried  out  in  good  faith under subsection (u) if the
30    substances involved were controlled substances.
31        Nothing in this subsection (y) or in this  Act  prohibits
32    the   manufacture,   preparation,  propagation,  compounding,
33    processing, packaging, advertising or distribution of a  drug
34    or  drugs by any person registered pursuant to Section 510 of
 
                            -9-                LRB9100184RCpc
 1    the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360).
 2        (y-1)  "Mail-order pharmacy" means  a  pharmacy  that  is
 3    located in a state of the United States, other than Illinois,
 4    that  delivers,  dispenses or distributes, through the United
 5    States Postal Service or other common  carrier,  to  Illinois
 6    residents, any substance which requires a prescription.
 7        (z)  "Manufacture"  means  the  production,  preparation,
 8    propagation,  compounding,  conversion  or  processing  of  a
 9    controlled  substance,  either  directly  or  indirectly,  by
10    extraction    from   substances   of   natural   origin,   or
11    independently  by  means  of  chemical  synthesis,  or  by  a
12    combination  of  extraction  and  chemical   synthesis,   and
13    includes  any  packaging  or  repackaging of the substance or
14    labeling of its container, except that  this  term  does  not
15    include:
16             (1)  by   an   ultimate  user,  the  preparation  or
17        compounding of a controlled substance for his own use; or
18             (2)  by a  practitioner,  or  his  authorized  agent
19        under  his  supervision,  the  preparation,  compounding,
20        packaging, or labeling of a controlled substance:
21                  (a)  as  an  incident  to  his administering or
22             dispensing of a controlled substance in  the  course
23             of his professional practice; or
24                  (b)  as   an   incident   to  lawful  research,
25             teaching or chemical analysis and not for sale.
26        (aa)  "Narcotic drug" means any of the following, whether
27    produced directly or indirectly by extraction from substances
28    of natural origin, or  independently  by  means  of  chemical
29    synthesis,  or  by  a  combination of extraction and chemical
30    synthesis:
31             (1)  opium  and  opiate,  and  any  salt,  compound,
32        derivative, or preparation of opium or opiate;
33             (2)  any  salt,  compound,  isomer,  derivative,  or
34        preparation thereof which  is  chemically  equivalent  or
 
                            -10-               LRB9100184RCpc
 1        identical  with  any  of  the  substances  referred to in
 2        clause (1), but not including the isoquinoline  alkaloids
 3        of opium;
 4             (3)  opium poppy and poppy straw;
 5             (4)  coca  leaves  and  any salts, compound, isomer,
 6        salt of an isomer, derivative,  or  preparation  of  coca
 7        leaves  including  cocaine  or  ecgonine,  and  any salt,
 8        compound,  isomer,  derivative,  or  preparation  thereof
 9        which is chemically equivalent or identical with  any  of
10        these  substances,  but  not  including decocainized coca
11        leaves or extractions of coca leaves which do not contain
12        cocaine or ecgonine (for the purpose of  this  paragraph,
13        the   term  "isomer"  includes  optical,  positional  and
14        geometric isomers).
15        (bb)  "Nurse" means a registered nurse licensed under the
16    Nursing and Advanced Practice Nursing Act.
17        (cc)  "Official prescription blanks" means the triplicate
18    prescription forms supplied to prescribers by the  Department
19    for  prescribing  Schedule  II  Designated Product controlled
20    substances.
21        (dd)  "Opiate" means any substance  having  an  addiction
22    forming or addiction sustaining liability similar to morphine
23    or  being  capable of conversion into a drug having addiction
24    forming or addiction sustaining liability.
25        (ee)  "Opium  poppy"  means  the  plant  of  the  species
26    Papaver somniferum L., except its seeds.
27        (ff)  "Parole and Pardon  Board"  means  the  Parole  and
28    Pardon  Board  of  the  State  of  Illinois  or its successor
29    agency.
30        (gg)  "Person"   means   any   individual,   corporation,
31    mail-order pharmacy, government or  governmental  subdivision
32    or  agency,  business  trust,  estate,  trust, partnership or
33    association, or any other entity.
34        (hh)  "Pharmacist"  means  any   person   who   holds   a
 
                            -11-               LRB9100184RCpc
 1    certificate  of  registration  as  a registered pharmacist, a
 2    local  registered  pharmacist  or  a   registered   assistant
 3    pharmacist under the Pharmacy Practice Act of 1987.
 4        (ii)  "Pharmacy"  means any store, ship or other place in
 5    which pharmacy  is  authorized  to  be  practiced  under  the
 6    Pharmacy Practice Act of 1987.
 7        (jj)  "Poppy straw" means all parts, except the seeds, of
 8    the opium poppy, after mowing.
 9        (kk)  "Practitioner"   means   a  physician  licensed  to
10    practice medicine in all its branches,  dentist,  podiatrist,
11    veterinarian,  scientific investigator, pharmacist, physician
12    assistant, advanced practice nurse, licensed practical nurse,
13    registered nurse, hospital, laboratory, or pharmacy, or other
14    person licensed, registered, or otherwise lawfully  permitted
15    by  the  United States or this State to distribute, dispense,
16    conduct research  with  respect  to,  administer  or  use  in
17    teaching  or chemical analysis, a controlled substance in the
18    course of professional practice or research.
19        (ll)  "Pre-printed   prescription"   means   a    written
20    prescription   upon   which  the  designated  drug  has  been
21    indicated prior to the time of issuance.
22        (mm)  "Prescriber" means a physician licensed to practice
23    medicine  in  all  its  branches,  dentist,   podiatrist   or
24    veterinarian who issues a prescription, a physician assistant
25    who  issues  a  prescription  for  a  Schedule  III, IV, or V
26    controlled substance as delegated by a physician licensed  to
27    practice  medicine in all its branches in accordance with the
28    written  guidelines  required  under  Section  7.5   of   the
29    Physician  Assistant  Practice  Act  of  1987, or an advanced
30    practice nurse with prescriptive authority, as delegated by a
31    physician licensed to practice medicine in all its  branches,
32    in  accordance  with  a written collaborative agreement under
33    Sections 15-15 and 15-20 of the Nursing and Advanced Practice
34    Nursing Act.
 
                            -12-               LRB9100184RCpc
 1        (nn)  "Prescription" means a lawful  written,  facsimile,
 2    or  verbal order of a physician licensed to practice medicine
 3    in all its branches, dentist, podiatrist or veterinarian  for
 4    any  controlled  substance,  of  a  physician assistant for a
 5    Schedule III, IV, or V controlled substance as delegated by a
 6    physician licensed to practice medicine in all  its  branches
 7    in  accordance  with  the  written  guidelines required under
 8    Section 7.5 of the Physician Assistant Practice Act of  1987,
 9    or  of  an  advanced practice nurse who issues a prescription
10    for a Schedule III, IV, or V controlled  substance,  pursuant
11    to  prescriptive  authority delegated by a physician licensed
12    to practice medicine in all its branches, in accordance  with
13    a  written  collaborative  agreement under Sections 15-15 and
14    15-20 of the Nursing and Advanced Practice Nursing Act.
15        (oo)  "Production"  or   "produce"   means   manufacture,
16    planting, cultivating, growing, or harvesting of a controlled
17    substance.
18        (pp)  "Registrant"  means every person who is required to
19    register under Section 302 of this Act.
20        (qq)  "Registry number" means the number assigned to each
21    person authorized to handle controlled substances  under  the
22    laws of the United States and of this State.
23        (rr)  "State"  includes  the  State  of  Illinois and any
24    state, district, commonwealth, territory, insular  possession
25    thereof,  and  any area subject to the legal authority of the
26    United States of America.
27        (ss)  "Ultimate  user"  means  a  person   who   lawfully
28    possesses  a  controlled substance for his own use or for the
29    use of a member of his household or for administering  to  an
30    animal owned by him or by a member of his household.
31    (Source:  P.A.  89-202,  eff.  10-1-95;  89-507, eff. 7-1-97;
32    90-116, eff. 7-14-97; 90-742, eff. 8-13-98.)

33        (720 ILCS 570/316 new)
 
                            -13-               LRB9100184RCpc
 1        Sec. 316.  Animal control  facility  and  animal  shelter
 2    registration.
 3        (a)  An  animal  shelter  or  animal control facility may
 4    apply  to  the  Department  of  Professional  Regulation  for
 5    registration pursuant to the applicable  provisions  of  this
 6    Act  for  the  sole  purpose of being authorized to purchase,
 7    possess, and administer  sodium  pentobarbital  to  euthanize
 8    injured,  sick,  homeless,  or  unwanted  domestic  pets  and
 9    animals.   Any  animal  shelter or animal control facility so
10    registered shall not permit a  person  to  administer  sodium
11    pentobarbital  unless  the  person  has demonstrated adequate
12    knowledge of the potential hazards and proper  techniques  to
13    be used in administering this drug.
14        The  Department  of  Professional  Regulation may issue a
15    limited registration to carry  out  the  provisions  of  this
16    Section.   The  Department  of  Professional Regulation shall
17    promulgate rules that it deems  necessary  to  insure  strict
18    compliance   with   the  provisions  of  this  Section.   The
19    Department of Professional Regulation may suspend  or  revoke
20    registration upon determination that the person administering
21    sodium  pentobarbital has not demonstrated adequate knowledge
22    as provided  in  this  subsection  (a).   This  authority  is
23    granted  in  addition to any other power to suspend or revoke
24    registration as provided by law.
25        (b)  Animal  shelters  and  animal   control   facilities
26    registered  with  the  Department  of Professional Regulation
27    under this  Act  and  authorized  to  euthanize  animals  may
28    purchase,  possess,  and administer approved legend drugs for
29    the sole purpose of sedating  animals  prior  to  euthanasia,
30    when  necessary,  and  for  use in chemical capture programs.
31    For the purposes of this  Section,  "approved  legend  drugs"
32    means  those  legend  drugs  designated  by the Department of
33    Professional Regulation by rule as being approved for use  by
34    animal  shelters  and  animal  control  facilities for animal
 
                            -14-               LRB9100184RCpc
 1    sedating or  capture  and  does  not  include  any  substance
 2    regulated  under  this  Act.   Any  animal  shelter or animal
 3    control facility so registered shall not  permit  persons  to
 4    administer   any   legend   drugs   unless   the  person  has
 5    demonstrated  to  the  satisfaction  of  the  Department   of
 6    Professional  Regulation  adequate knowledge of the potential
 7    hazards involved in and the proper techniques to be  used  in
 8    administering the drugs.
 9        The   Department   of   Professional   Regulation   shall
10    promulgate  rules  to  regulate the purchase, possession, and
11    administration of legend drugs by animal shelters and  animal
12    control  facilities  and to insure strict compliance with the
13    provisions of this Section.  These rules shall  require  that
14    the   storage,   inventory   control,   administration,   and
15    recordkeeping  for  approved  legend  drugs  conform  to  the
16    standards   adopted   by   the   Department  of  Professional
17    Regulation under this Act to regulate the use  of  controlled
18    substances  by animal shelters and animal control facilities.
19    The Department of  Professional  Regulation  may  suspend  or
20    revoke  a  registration  under this Act upon determination by
21    the Department of Professional  Regulation  that  the  person
22    administering  legend  drugs  has  not  demonstrated adequate
23    knowledge as provided in this subsection (b).  This authority
24    is granted in addition to  any  other  power  to  suspend  or
25    revoke a registration as provided by law.

[ Top ]